Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Allen

Showing results (181-190 of 249) with videos related to

Pageof 25
Sort By:
Translational Psychiatry|September 14, 2020
A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosisCathy Davies, Robin Wilson, Elizabeth Appiah-Kusi, et al.
Biological Psychiatry|July 20, 2010
Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosisJames M Stone, Oliver D Howes, Alice Egerton, et al.
Schizophrenia Bulletin|March 27, 2012
Auditory hallucinations in schizophrenia and nonschizophrenia populations: a review and integrated model of cognitive mechanismsFlavie Waters, Paul Allen, André Aleman, et al.
Schizophrenia Research|November 29, 2007
Increased superior temporal activation associated with external misattributions of self-generated speech in schizophreniaCynthia H Y Fu, Michael J Brammer, Lidia Yágüez, et al.
Psychological Medicine|October 17, 2023
Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiolCathy Davies, Matthijs G Bossong, Daniel Martins, et al.
JAMA Psychiatry|November 15, 2018
Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for PsychosisMatthijs G Bossong, Mathilde Antoniades, Matilda Azis, et al.
Journal of Psychiatry & Neuroscience : JPN|December 2, 2009
Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studiesPaolo Fusar-Poli, Anna Placentino, Francesco Carletti, et al.
Psychiatry Research|April 18, 2016
Prevalence and implications of Truman symptoms in subjects at ultra high risk for psychosisLuis Madeira, Ilaria Bonoldi, Matteo Rocchetti, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 4, 2021
Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary reportCathy Davies, Elizabeth Appiah-Kusi, Robin Wilson, et al.
The International Journal of Neuropsychopharmacology|September 25, 2009
Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiolPaolo Fusar-Poli, Paul Allen, Sagnik Bhattacharyya, et al.
Pageof 25

Showing results (181-190 of 249) with videos related to

Sort By:
Pageof 25
Translational Psychiatry|September 14, 2020
A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosisCathy Davies, Robin Wilson, Elizabeth Appiah-Kusi, et al.
Biological Psychiatry|July 20, 2010
Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosisJames M Stone, Oliver D Howes, Alice Egerton, et al.
Schizophrenia Bulletin|March 27, 2012
Auditory hallucinations in schizophrenia and nonschizophrenia populations: a review and integrated model of cognitive mechanismsFlavie Waters, Paul Allen, André Aleman, et al.
Schizophrenia Research|November 29, 2007
Increased superior temporal activation associated with external misattributions of self-generated speech in schizophreniaCynthia H Y Fu, Michael J Brammer, Lidia Yágüez, et al.
Psychological Medicine|October 17, 2023
Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiolCathy Davies, Matthijs G Bossong, Daniel Martins, et al.
JAMA Psychiatry|November 15, 2018
Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for PsychosisMatthijs G Bossong, Mathilde Antoniades, Matilda Azis, et al.
Journal of Psychiatry & Neuroscience : JPN|December 2, 2009
Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studiesPaolo Fusar-Poli, Anna Placentino, Francesco Carletti, et al.
Psychiatry Research|April 18, 2016
Prevalence and implications of Truman symptoms in subjects at ultra high risk for psychosisLuis Madeira, Ilaria Bonoldi, Matteo Rocchetti, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 4, 2021
Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary reportCathy Davies, Elizabeth Appiah-Kusi, Robin Wilson, et al.
The International Journal of Neuropsychopharmacology|September 25, 2009
Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiolPaolo Fusar-Poli, Paul Allen, Sagnik Bhattacharyya, et al.
Pageof 25